Okeiro

Paris, France Founded: 2023 • Age: 3 yrs
Provider of AI-powered predictive analytics for transplant and chronic disease management
Annual revenue - Latest available
Total funding $11.0M 1 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Okeiro

Okeiro is a company based in Paris (France) founded in 2023 by Pierrick Arnal and Alexandre Loupy. Okeiro has raised $10.98 million across 1 funding round from investors including Alven, Forepont Capital Partners and Red River West.

  • Headquarter Paris, France
  • Founders Pierrick Arnal, Alexandre Loupy
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $10.98 M (USD)

    in 1 rounds

  • Latest Funding Round
    $10.98 M (USD), Series A

    Apr 10, 2025

  • Investors
    Alven

    & 2 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Okeiro

Okeiro has successfully raised a total of $10.98M through 1 strategic funding round. The most recent funding activity was a Series A round of $10.98 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Okeiro

Okeiro has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Alven, Forepont Capital Partners and Red River West.

All
Venture Fund
Investor Description Founded Year Domain Location
Early-stage investments are targeted by Alven, a venture capital firm.
Locked Locked Locked
-
Locked Locked Locked
European tech companies are supported for U.S. market expansion.
Locked Locked Locked
Premium access

Investor details for Okeiro

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Okeiro

Investments
Premium access

Investment portfolio details for Okeiro

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Okeiro

Premium access

Detailed financials for Okeiro

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Okeiro Comparisons

Okeiro Primary company
Description
Provider of AI-powered predictive analytics for transplant a...
Location
Paris, France
Founded Year
2023
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Okeiro

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Okeiro

Premium access

Detailed competitors of Okeiro

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Okeiro

Premium access

Complete news archive for Okeiro

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Okeiro

Okeiro was founded in 2023 and raised its 1st funding round 2 years after it was founded.

Okeiro is headquartered in Paris, France.

Pierrick Arnal is the current CEO of Okeiro. They have also founded this company.

Okeiro is a funded company, having raised a total of $10.98M across 1 funding round to date.

Provider of AI-powered predictive analytics for transplant and chronic disease management. This platform uses predictive algorithms validated for clinical care and research to improve patient monitoring. It offers tools for healthcare professionals to anticipate clinical changes, enabling proactive interventions. Patients benefit from improved medical follow-up and enhanced communication with caregivers. Pharmaceutical companies can leverage the platform to accelerate clinical trials through faster evaluation of research results. The technology centralizes data, providing a clear, instant overview and intelligent alerts to detect early warning signs of complications. A dedicated nurse supports telehealth monitoring, freeing up clinicians time. The platform also facilitates research through virtualized clinical trials and the use of predictive models.

Okeiro has 3 investors. Key investors include Alven, Forepont Capital Partners, and Red River West.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available